Skip to main content
Log in

Human tumor-associated antigens identified by monoclonal antibodies

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Conclusions

Monoclonal antibodies have been obtained that are specific for cell surface antigens of human tumors. Some of these antigens are tissue type specific tumor antigens, most strongly expressed on tumors of the same histological type. The antigens identified by the monoclonal antibodies are primarily normal differentiation antigens that are expressed more strongly on neoplastic cells than on most normal adult cells. For several antigens, the higher degree of antigen expression on neoplastic cells appear to be adequate for diagnostic and therapeutic purposes. Future work in this area is likely to have far-reaching consequences for the clinical handling of human cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Accola R S, Buchegger F, Carrel S, Mach J-P (1981) Monoclonal antibodies against carcinoembryonic antigens and their possible applications. In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol. 3. North-Holland Biomedical Press, Amsterdam, p209

    Google Scholar 

  2. Aisenberg AC, Wilkes B M (1981) Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia. Cancer Res 41: 4810

    Google Scholar 

  3. Atassi M Z (1978) Precise determination of the entire antigenic structure of lysozyme: molecular features of protein antigenic structures and potential of surface stimulation synthesis — a powerful new concept for protein binding sites. Immunochemistry 15: 909

    Google Scholar 

  4. Ballou B, Levine G, Hakala TR, Solter D (1979) Tumor location detected with radioactively monoclonal antibody and external scintigraphy. Science 206: 844

    Google Scholar 

  5. Bast R C Jr, Zbar B, Borsos T, Rapp H J (1974) BCG and cancer. N Engl J Med 290: 1413

    Google Scholar 

  6. Bast R C Jr, Feeney M, Lazarus H, Nadler L M, Colvin R B, Knapp R C (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331

    Google Scholar 

  7. Bernstein I D, Tam M R, Nowinski R C (1980) Mouse leukemia therapy with monoclonal antibodies against a thymus differentiation antigen. Science 207: 68

    Google Scholar 

  8. Bluestone J A, Sharrow S O, Epstein S L, Ozato K, Sachs D H (1981) Induction of anti-H-2 antibodies without alloantigen exposure by in vivo administration of anti-idiotype. Nature 291: 233

    Google Scholar 

  9. Blythman H E, Casellas P, Gros O, Gros P, Jansen F K, Paolucci F, Pau B, Vidal H (1981) Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kills tumour cells. Nature 290: 145

    Google Scholar 

  10. Bowman W P, Melvin S L, Aur R J A, Mauer A M (1981) A clinical perspective on cell markers in acute lymphocytic leukemia. Cancer Res 41: 4794

    Google Scholar 

  11. Brown J P, Hellström K E, Hellström I (to be published) Indirect 125I-labeled protein A assay for monoclonal antibodies to cell surface antigens. Methods Enzymol

  12. Brown J P, Hellström K E, Hellström I (1981) Use of monoclonal antibodies for quantitative analysis of antigens in normal and neoplastic tissues. Clin Chem 27: 1592

    Google Scholar 

  13. Brown J P, Hewick R M, Hellström I, Hellström K E, Doolittle R F, Dreyer W J (1982) Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature 296: 171

    Google Scholar 

  14. Brown J P, Nishiyama K, Hellström I, Hellström K E (1981) Structural characterization of human melanoma-associated antigen p97 using monoclonal antibodies. J Immunol 127: 539

    Google Scholar 

  15. Brown J P, Woodbury R G, Hart C E, Hellström I, Hellström K E (1981) Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci USA 78: 539

    Google Scholar 

  16. Brown J P, Wright P W, Hart C E, Woodbury R G, Hellström K E, Hellström I (1980) Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies. J Biol Chem 255: 4980

    Google Scholar 

  17. Bubenik J, Perlmann P, Helmstein K, Moberger G (1970) Cellular and humoral immune response to human urinary bladder carcinomas. Int J Cancer 5: 310

    CAS  PubMed  Google Scholar 

  18. Burtin P, Sabine M C, Chavanel G (1977) A comparative study of the localization of CEA and NCA2 in cancerous and normal gastointestinal tissues. Int J Cancer 19: 634

    Google Scholar 

  19. Byrd R L, Jonak Z L, Kennett K H (1982) Monoclonal antibodies against human neuroblastomas and leukemias: detection of metastasis and of molecules involved in growth regulation. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 219

    Google Scholar 

  20. Carrel S, Accolla R S, Carmagnola A L, Mach J-P (1980) Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res 40: 2523

    Google Scholar 

  21. Carrel S, Accolla R S, Gross N, Mach J-P (1981) Human melanoma-associated antigens identified by monoclonal antibodies. In: Hämmerling GJ, Hämmerling U, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Elsevier/North-Holland Biomedical Press, Amsterdam, p 174

    Google Scholar 

  22. Cassellas P, Brown J P, Gros O, Gros P, Hellström I, Jansen F K, Poncelet P, Roncucci R, Vidal H, Hellström K E (to be published) Immunotoxin potentiated by ammonium chloride specifically and efficiently kills human melanoma cells.

  23. Colcher D, Horan Hand P, Nuti M, Schlom J (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 78: 3199

    Google Scholar 

  24. Cornain S, de Vries J E, Collard J, Vennegoor C, Wingerden I V, Rumke P (1975) Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer 19: 981

    Google Scholar 

  25. Cuttitta F, Rosen S, Gazdar A F, Minna J D (1981) Monoclonal antibodies that demonstrate specificity for several types of human lung cancer. Proc Natl Acad Sci USA 78: 4591

    Google Scholar 

  26. Dantas M E, Brown J P, Thomas M R, Robinson W A, Glode L M (to be published) Detection of melanoma cells in bone marrow using monoclonal antibodies: a comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF). Cancer

  27. Dillman R O, Sobol R E, Collins H, Beauregard J, Royston I (1982) T101 monoclonal antibody therapy in chronic lymphocytic leukemia. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 151

    Google Scholar 

  28. Dippold W G, Lloyd K O, Li L T C, Ikeda H, Oettgen H F, Old L J (1980) Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 77: 6114

    Google Scholar 

  29. Doolittle R F (1981) Similar amino acid sequences: chance or common ancestry? Science 214: 149

    CAS  PubMed  Google Scholar 

  30. Eisen H N, Sakato N, Hall S J (1975) Myeloma proteins as tumor-specific antigens. In: Murphy G P (ed) Cancer and transplantation. Grune and Stratton, New York, p 71

    Google Scholar 

  31. Embleton M J, Gunn B, Byers V S, Baldwin R W (1981) Anti-tumor reactions of monoclonal antibody against a human osteogenic sarcoma cell line. Br J Cancer 43: 582

    Google Scholar 

  32. Galloway D R, McDabe R P, Pellegrino M A, Ferrone S, Reisfeld R A (1981) Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera. J Immunol 126: 62

    Google Scholar 

  33. Garrigues H J, Tilgen W, Hellström I, Franke W, Hellström K E (1982) Detection of a human melanoma-associated antigen p97, in histological sections of primary human melanomas. Int J Cancer 29: 511

    Google Scholar 

  34. Ghose T, Blair A H (1978) Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. J Natl Cancer Inst 61: 657

    Google Scholar 

  35. Gilliland D G, Steplewski Z, Collier R J, Mitchell K F, Chang T H, Koprowski H (1980) Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. Proc Natl Acad Sci USA 77: 4539

    Google Scholar 

  36. Gold P, Freedman S O (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467

    Google Scholar 

  37. Goldenberg D M, DeLand F, Kim E, Bennett S, Primus F J, Van Nagell J R, Estes N, DeSimone P, Rayburn P (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298: 1384

    Google Scholar 

  38. Greaves M F (1979) Clinical value of leukaemia cell markers. In: Boelsma E, Rumke P (eds) Tumor markers. Impact and prospects. Elsevier/North-Holland Biomedical Press, Amsterdam, p 229

    Google Scholar 

  39. Greaves M F (1981) Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 41: 4752

    Google Scholar 

  40. Hakomori S I (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 733: 764

    Google Scholar 

  41. Halliday W J, Maluish A E, Little J H, Davis N C (1975) Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma. Int J Cancer 16: 645

    Google Scholar 

  42. Hamblin T J, Abdul-Abad A K, Gordon J, Stevenson F K, Stevenson G T (1980) Preliminary experience in treating lymphocytic leukemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer 42: 495

    Google Scholar 

  43. Hatzubai A, Maloney G G, Levy R (1981) The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. J Immunol 126: 2397

    Google Scholar 

  44. Hellström I, Brown J P, Hellström K E (1981) Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in clomplement-dependent cytotoxicity. J Immunol 127: 157

    Google Scholar 

  45. Hellström I, Brown J P, Klitzman J M, Hellström K E (1978) A highly sensitive and reproducible microcytotoxicity assay for demonstrating cytotoxic antibodies to cell surface antigens. J Immunol Methods 22: 369

    Google Scholar 

  46. Hellström I, Hellström K E, Shepard T H (1970) Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium. Int J Cancer 6: 346

    Google Scholar 

  47. Hellström I, Hellström K E, Pierce G E, Yang J P S (1968) Cellular and humoral immunity to different types of human neoplasms. Nature 220: 1352

    Google Scholar 

  48. Hellström I, Hellström K E, Sjögren H O, Warner G A (1981) Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer 7: 1

    Google Scholar 

  49. Hellström I, Hellström K E, Yeh M-Y (1981) Lymphocyte-dependent antibodies to antigen 3.1, a cell surface antigen expressed by a subgroup of human melanomas. Int J Cancer 27: 281

    Google Scholar 

  50. Hellström I, Rollins N, Settle S, Chapman P, Chapman W H, Hellström K E (1982) Monoclonal antibodies to two mouse bladder carcinoma antigens. Int J Cancer 29: 175

    Google Scholar 

  51. Hellström K E, Brown J P (1979) Tumor antigens. In: Sela M (ed) The antigens. Academic Press, New York, p 1

    Google Scholar 

  52. Hellström K E, Brown J P, Hellström I (1980) Monoclonal antibodies to tumor antigens. Contemp Top Immunobiol 11: 117

    Google Scholar 

  53. Herberman R B (1974) Cell-mediated immunity to tumor cells. Adv Cancer Res 19: 207

    Google Scholar 

  54. Herlyn M, Clark W H Jr, Mastangelo MJ, Guerry D IV, Elder D E, LaRosse D, Hamilton R, Bondi E, Tuthill R, Steplewski Z (1980) Specific immunoreactivity of monoclonal antimelanoma antibodies. Cancer Res 40: 3602

    Google Scholar 

  55. Herlyn D, Herlyn M, Steplewski Z, Koprowski H (1979) Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and coloractal carcinoma. Eur J Immunol 9: 657

    Google Scholar 

  56. Herlyn M, Steplewski Z, Herlyn D, Koprowski Z (1979) Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76: 1438

    Google Scholar 

  57. Herlyn D, Steplewski Z, Herlyn M, Koprowski H (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40: 717

    Google Scholar 

  58. Hollinshead A C, Herberman R B, Jaffurs W J, Alpert L K, Minton J P, Harris J E (1974) Soluble membrane antigens of human malignant melanoma cells. Cancer 34: 1235

    Google Scholar 

  59. Hosoi S, Nakamura T, Higashi S, Yamamuro T, Toyama S, Shinomiya K, Mikawa H (1982) Detection of human osteosarcoma-associated antigen(s) by monoclonal antibodies. Cancer Res 42: 654

    Google Scholar 

  60. Hurwitz E, Levy R, Maron R, Wilchek M, Arnon R, Sela M (1975) The covalent binding of daunomycin and adriamycin to antibodies with retention of both drug and antibody activities. Cancer Res 34: 1175

    Google Scholar 

  61. Imai K, Wilson B S, Kay N E, Ferrone S (1981) Monoclonal antibodies to human melanoma cells: comparisons of serological results of several laboratories and molecular profile of melanoma-associated antigens. In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol 3. Elsevier/North-Holland Biomedical Press, Amsterdam, p 183

    Google Scholar 

  62. Iwaki Y, Kasai M, Terasaki P I, Bernoco D, Park M S, Cicciarelli J, Heintz R, Saxton R E, Burk M W, Morton D L (1982) Monoclonal antibody against A1 Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma. Cancer Res 42: 409

    Google Scholar 

  63. Jansen F K, Blythman H E, Carriere D, Casellas P, Gros O, Gros P, Paolucci F, Pau B, Poncelet P, Richer G, Vidal H, Voisin G A (1981) Assembly and activity of conjugates between monoclonal antibodies and the toxic subunit of ricin (immunotoxins). In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol 3. Elsevier/North-Holland Biomedical Press, Amsterdam, p 229

    Google Scholar 

  64. Kaplan H S (1982) Closing remarks. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, Mew York, p 113

    Google Scholar 

  65. Kasai M, Saxton R E, Holmes E C, Burk M W, Morton D L (1981) Membrane antigens detected on human lung carcinoma cells by hybridoma monoclonal antibody. J Surg Res 30: 403

    Google Scholar 

  66. Kennel S J, Foote L J, Lankford P K (1981) Analysis of surface proteins of mouse lung carcinomas using monoclonal antibodies. Cancer Res 41: 3465

    Google Scholar 

  67. Kennett R H, Gilbert F (1979) Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain. Science 203: 1120

    Google Scholar 

  68. Kersey J H, LeBien T W, Abramson C S, Newman R, Sutherland D R, Greaves M (1981) p 24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med 153: 726

    Google Scholar 

  69. Kirch M E, Lee T, Hämmerling U (1981) Treatment of transplanted murine leukemias with monoclonal antibody; a model for passive immunotherapy. In: Hämmerling U, Hämmerling G J, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Research monographs in immunology, Vol. 3. Elsevier/North-Holland Biomedical Press, Amsterdam, p 221

    Google Scholar 

  70. Klein E, Holterman O A, Papermaster B, Milgrom H, Rosner D, Klein L, Walker M J, Zbar B (1973) Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives. Natl Cancer Inst Monogr 39: 229

    Google Scholar 

  71. Klein G, Clifford P, Klein E, Stjernswärd J (1966) Search for tumor-specific immune reactions in Burkitt's lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci USA 55: 1628

    Google Scholar 

  72. Klitzman J M, Brown J P, Hellström K E, Hellström I (1980) Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas. J Immunol 124: 2552

    Google Scholar 

  73. Köhler G, Milstein C (1975) Continuous culture of fused cells secreting antibodies of predefined specificity. Nature 256: 495

    CAS  PubMed  Google Scholar 

  74. Koprowski H, Sears H, Herlyn M, Steplewski Z (1981) Specific antigen in serum of patients with colorectal carcinoma. Science 212: 53

    Google Scholar 

  75. Koprowski H, Steplewski Z, Herlyn D, Herlyn M (1978) Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 75: 3405

    Google Scholar 

  76. Koprowski H, Steplewski Z (1981) Human solid tumor antigens defined by monoclonal antibodies. In: Hämmerling G J, Hämmerling U, Kearney J F (eds) Monoclonal antibodies and T-cell hybridomas. Elsevier/North-Holland Biomedical Press, Amsterdam, p 161

    Google Scholar 

  77. Krolick K A, Isakson P C, Uhr J W, Vitetta E S (1979) BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. Immunol Rev 48: 81

    Google Scholar 

  78. Krolick K A, Villemez C, Isakson P, Uhr J W, Vitetta E S (1980) Selective killing of normal or neoplastic B-cells by antibodies coupled to the A chain of ricin. Proc Natl Acad Sci USA 77: 5419

    Google Scholar 

  79. Larson S M, Brown J P, Wright P W, Carrasquillo J A, Hellström I, Hellström K E (to be published) Imaging of melanoma with 131I-labelled monoclonal antibodies.

  80. LeBien T W, McKenna R W, Abramson C S, Gajl-Peczalska K J, Nesbit M E, Coccia P F, Bloomfiled C D, Brunning R D, Kersey J H (1981) Use of monoclonal antibodies, morphology, cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma. Cancer Res 41: 4776

    Google Scholar 

  81. Lennox E S (1982) Monoclonal antibodies and tumor antigens. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 5

    Google Scholar 

  82. Lewis M G, Ikonopisov R L, Nairn R C, Phillips T M, Hamilton-Fairly G, Bodenham D C, Alexander P (1969) Tumor-specific antibodies in human malignant melanoma and their relationship to extent of disease. Br Med J 3: 547

    Google Scholar 

  83. Levy R, Dilley J (1978) Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic hybridization. Proc Natl Acad Sci USA 75: 2411

    Google Scholar 

  84. Levy R, Dilley J, Fox R I, Warnke R (1979) A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci USA 76: 6552

    Google Scholar 

  85. Loop S M, Nishiyama K, Hellström I, Woodbury R G, Brown J P, Hellström K E (1981) Two human tumor-associated antigens, p 155 and p 210, detected by monoclonal antibodies. Int J Cancer 27: 775

    Google Scholar 

  86. Mach J-P, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso J-L, Schreyer M, Girardet C, Accola R S, Carrel S (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscinitigraphy. Immunol Today 2: 239

    Google Scholar 

  87. Magnani J, Brockhaus M, Smith D F, Ginsburg V, Blaszczyk M, Mitchell K, Steplewski Z, Koprowski H (1981) A monosialoganglioside is a monoclonal antibody-defined antigen of colorectal carcinoma. Science 212: 55

    Google Scholar 

  88. Masuho Y, Hara T, Noguchi T (1979) Preparation of hybrid of fragment Fab′ of antibody and fragment of a diphtheria toxin and its cytotoxicity. Biochem Biophys Res Commun 90: 320

    Google Scholar 

  89. McCoy J L, Jerome L F, Dean J H, Perlin E, Oldham R K, Char D H, Cohen M H, Felix E L, Herberman R B (1975) Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J Natl Cancer Inst 55: 19

    Google Scholar 

  90. Melvin S L (1981) Immunological definition of leukemia cell surface phenotypes. Cancer Res 41: 4790–4793

    Google Scholar 

  91. Metzgar R S, Bergoc P M, Moreno M A, Seigler H F (1973) Melanoma-specific antibodies produced in monkey by immunization with human melanoma cell lines. J Natl Cancer Inst 50: 1065

    Google Scholar 

  92. Miller G G, Nadler P I, Asano Y, Hodes R J, Sachs D H (1981) Induction of idiotype-bearing nuclease-specific helper T cells by in vivo treatment of anti-idiotype. J Exp Med 154: 23

    Google Scholar 

  93. Miller R A, Maloney D G, Levy R (1981) In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood 58: 78

    Google Scholar 

  94. Miller R A, Maloney D G, Warnke R, Levy R (1981) Treatment of B-cell lymphoma with monoclonal antibody anti-idiotype antibody. N Engl J Med 306: 517

    Google Scholar 

  95. Miller R A, Maloney D, Warnke R, McDougall R, Wood G, Kawakami T, Dilley J, Goris M L, Levy R (1982) Considerations for treatment with hybridoma antibodies. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 133

    Google Scholar 

  96. Mitchell K, Fuhrer Z, Steplewski Z, Koprowski Z (1980) Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies. Proc Natl Acad Sci USA 77: 7267

    Google Scholar 

  97. Miyazaki H, Beppu M, Terao T, Osawa T (1980) Preparation of antibody (IgG)-ricin, A-chain conjugate and its biologic activity. Gann 71: 766

    Google Scholar 

  98. Morgan A. C., Galloway, D. R., Reisfeld, R. A. (1981) Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. Hybridoma 1: 27

    Google Scholar 

  99. Morton D L, Eilber F R, Holmes E C, Hunt J S, Ketcham A S, Silverstein M J, Sparks F C (1974) BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg 180:635

    Google Scholar 

  100. Morton D L, Malmgren R A, Holmes E C, Ketcham A S (1968) Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64: 233

    Google Scholar 

  101. National Institute of Allergy and Infectious Diseases NIAID (1977) Manual of Tissue Typing Techniques, DHEW no. (NIH) 76–545, GPO, Washington, D. C., p 22

    Google Scholar 

  102. Omary M B, Trowbridge I S, Minowada J M (1980) Human cell-surface glycoprotein with unusual properties. Nature 286: 888

    MATH  Google Scholar 

  103. Order S E, Klein J L, Ettinger D, Alderson P, Siegelman S, Leichner P (1980) Use of isotopic immunoglobulin in cancer therapy. Cancer Res 40: 3001

    Google Scholar 

  104. Pullen D J, Falleta J M, Crist W M, Vogler L B, Dowell B, Humphrey G B, Blackstock R, Van Eys J, Cooper M D, Metzgar R S, Meydrech E F (1981) Southwest oncology group experience with immunological phenotyping in acute lymphocytic leukemia of childhood. Cancer Res 41: 4802

    Google Scholar 

  105. Raso V, Ritz J, Basala M, Schlossman S T (1982) Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Cancer Res 42: 457

    Google Scholar 

  106. Reisfeld R A, Morgan A C Jr, Bumol T F (1982) Discussion: Production and characterization of a monoclonal antibody to human melanoma associated antigens. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 183

    Google Scholar 

  107. Ritz J, Pesando J M, Notis-McConarty J, Lazarus H, Schlossman S F (1980) A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature 283: 583

    Google Scholar 

  108. Ritz J, Pesando J M, Notis-McConarty J, Clavell L A, Sallan S E, Schlossman S F (1981) Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. Cancer Res 41: 4771

    Google Scholar 

  109. Rose T M (1981) Characterization of the surface proteins of cells transformed or abortively-infected with Simian Virus 40. Ph. D. Thesis Université de Geneve, Switzerland

    Google Scholar 

  110. Ruberto G, Imai K, Natali P G, Wilson B S, Ferrone S (1982) Discussion: Analysis of monoclonal antibodies to human melanoma cells. In: Mitchell M S, Oettgen H F (eds) Hybridomas in cancer diagnosis and treatment. Raven Press, New York, p 191

    Google Scholar 

  111. Sallen S E, Ritz J, Pesando J, Gelbar R, O'Brien C, Hitchcock S, Coral F, Schlossman S F (1980) Cell surface antigens; prognostic implications in childhood acute lymphoblastic leukemia. Blood 55: 395

    CAS  PubMed  Google Scholar 

  112. Sandvig K, Olsnes S, Pihl A (1978) Chemical modification of the toxic lectins abrin and ricin. Eur J Biochem 84: 323

    Google Scholar 

  113. Schlom J, Wunderlich D, Teramoto Y A (1980) Generation of human monoclonal antibodies receive with human mammary carcinoma cells. Proc Natl Acad Sci USA 77: 6841

    Google Scholar 

  114. Shiku H, Takahashi T, Oettgen H F, Old L J (1976) Cell surface antigens of human malignant melanoma: II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med 144: 873

    Google Scholar 

  115. Sikora K, Wright R (1981) Human monoclonal antibodies to lung-cancer antigens. Br J Cancer 43: 696

    Google Scholar 

  116. Sondel P M, O'Brien C, Porter L, Schlossman S F, Chess L (1976) Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: Requirement for a proliferative trigger in vitro. J Immunol 117: 2197

    Google Scholar 

  117. Steplewski Z, Herlyn M, Herlyn D, Clark W H, Koprowski Z (1979) Reactivity of monoclonal antimelanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol 9: 94

    Google Scholar 

  118. Sternberger L A (1979) The unlabeled antibody peroxidase-antiperoxidase (PAP) method In: Immunocytochemistry. John Wiley Sons, New York, p 104

    Google Scholar 

  119. Stevenson G T, Elliott E V, Stevenson F K (1977) Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc 36: 2268

    Google Scholar 

  120. Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M (1981) Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci USA 78: 4515

    Google Scholar 

  121. Trowbridge I S, Domingo D L (to be published) Effects on growth of human tumor cells of anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates. Nature

  122. Trowbridge I S, Omary M B (1981) Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78: 3039

    Google Scholar 

  123. Ueda R, Shiku H, Pfreundschuh M, Takahashi T, Li L T C, Whitmore W, Oettgen H F, Old L J (1979) Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med 150: 564

    Google Scholar 

  124. Uotila M, Envall E, Ruoslathi E (1980) Monoclonal antibodies to human alphafetoprotein. Mol Immunol 17: 791

    Google Scholar 

  125. Woodbury R G, Brown J P, Yeh M-Y, Hellström I, Hellström K E (1980) Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci USA 77: 2183

    Google Scholar 

  126. Woodbury R G, Brown J P, Loop S M, Hellström K E, Hellström I (1981) Analysis of normal and neoplastic human tissues for the tumor-associated protein p97. Int J Cancer 27: 145

    Google Scholar 

  127. Yeh M-Y, Hellström I, Brown J P, Warner G A, Hansen J A, Hellström K E (1979) Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci USA 76: 2927

    Google Scholar 

  128. Yeh M-Y, Hellström I, Hellström K E (1981) Clonal variation in expression of a human melanoma antigen defined by a monoclonal antibody. J Immunol 126: 1264

    Google Scholar 

  129. Yeh M-Y, Hellström I, Abe K, Hakomori S, Hellström K E (to be published) A cell surface antigen which is present in the ganglioside fraction and shared by human melanoma. Int J Cancer

  130. Zamcheck N, Moore T L, Dhar P, Kupchik H (1972) Immunologic diagnosis and prognosis of human digestive-tract cancer: carcinoembryonic antigens. N Engl J Med 286: 83

    Google Scholar 

  131. Zighelboim J, Bick A, Durantez A (1977) “Recognition by human and rabbit sera of common antigens to leukemia blast cells, peripheral blood B-lymphocytes, and monocytes. Cancer Res 37: 3656

    Google Scholar 

  132. Zipf T F, Fox R L, Dilley J, Levy R (1981) Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies. Cancer Res 41: 4786

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by grants CA 14135, 19148, 19149, CA 25558, CA 27841 from the National Institutes of Health, and IM 241A from the American Cancer Society. The authors wish to acknowledge collaboration with Drs. M.-Y. Yeh, R. G. Woodbury, S. M. Larson, and K. Nishiyama

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hellström, K.E., Hellström, I. & Brown, J.P. Human tumor-associated antigens identified by monoclonal antibodies. Springer Semin Immunopathol 5, 127–146 (1982). https://doi.org/10.1007/BF00199792

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199792

Keywords

Navigation